ResMed Inc. (RMD)
- Previous Close
180.35 - Open
182.59 - Bid 183.39 x 800
- Ask 183.59 x 1000
- Day's Range
181.70 - 184.45 - 52 Week Range
132.24 - 243.52 - Volume
405,689 - Avg. Volume
1,062,972 - Market Cap (intraday)
26.928B - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
30.31 - EPS (TTM)
6.04 - Earnings Date Apr 25, 2024
- Forward Dividend & Yield 1.92 (1.06%)
- Ex-Dividend Date Feb 7, 2024
- 1y Target Est
202.68
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
www.resmed.comRecent News: RMD
Performance Overview: RMD
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RMD
Valuation Measures
Market Cap
26.53B
Enterprise Value
27.71B
Trailing P/E
29.86
Forward P/E
22.62
PEG Ratio (5yr expected)
1.70
Price/Sales (ttm)
5.91
Price/Book (mrq)
5.92
Enterprise Value/Revenue
6.15
Enterprise Value/EBITDA
19.38
Financial Highlights
Profitability and Income Statement
Profit Margin
19.77%
Return on Assets (ttm)
11.19%
Return on Equity (ttm)
21.66%
Revenue (ttm)
4.5B
Net Income Avi to Common (ttm)
890.39M
Diluted EPS (ttm)
6.04
Balance Sheet and Cash Flow
Total Cash (mrq)
217.86M
Total Debt/Equity (mrq)
31.04%
Levered Free Cash Flow (ttm)
812.89M
Research Analysis: RMD
Company Insights: RMD
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: RMD
RMD: Lowering target price to $194.00
RESMED INC has an Investment Rating of HOLD; a target price of $194.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRMD: Raising target price to $204.00
RESMED INC has an Investment Rating of HOLD; a target price of $204.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRMD: Lowering target price to $194.00
RESMED INC has an Investment Rating of HOLD; a target price of $194.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRMD: Raising target price to $204.00
RESMED INC has an Investment Rating of HOLD; a target price of $204.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target